Global At-Home Cancer Testing Market Size to Exceed USD 11.6 Billion by 2035 | CAGR of 4.30%
Category: HealthcareGlobal At-Home Cancer Testing Market Size to Exceed USD 11.6 Billion by 2035
According to a Research Report Published by Spherical Insights & Consulting, The Global At-Home Cancer Testing Market Size is expected to Grow from USD 7.3 Billion in 2024 to USD 11.6 Billion by 2035, at a CAGR of 4.30% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global At-Home Cancer Testing Market Size, Share, and COVID-19 Impact Analysis, By Sample Type (Blood Sample, Saliva Sample, Urine Sample, and Tissue Sample), By Cancer Type (Colon Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, and Others), By Test Type (Genetic Testing, Biomarker Testing, Immunological Testing, and Cell-Free DNA Testing), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/at-home-cancer-testing-market
The at-home cancer testing market involves the production of user-friendly kits for early cancer detection, screening, and monitoring, which enable individuals to collect samples at home for analysis. At-home cancer testing aids in detecting and screening cancer in its early, more treatable stage, sometimes before the occurrence of symptoms. Advancements in PoC testing technology make at-home testing more accessible and common. The integration of mobile applications with testing kits enables users to track prompts for follow-up tests and thereby consult healthcare professionals from home. The growing technological advancements in molecular diagnostics and AI are providing market growth opportunities for at-home cancer testing. Consumers' increasing demand for early diagnosis, personalized healthcare, and the convenience of self-testing are driving the at-home cancer testing market. On the contrary, the increased cost of at-home cancer testing kits, as well as accuracy & reliability issues related to the testing, are hampering the market growth.
The blood sample type segment dominated the market with a major share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the sample type, the at-home cancer testing market is divided into blood sample, saliva sample, urine sample, and tissue sample. Among these, the blood sample type segment dominated the market with a major share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Blood testing aids in measuring the elevated levels of markers and genetic mutations for early cancer detection. The increased use of blood samples due to their effectiveness in detecting various malignancies is driving the market.
The colon cancer segment accounted for the dominant market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the cancer type, the at-home cancer testing market is divided into colon cancer, breast cancer, prostate cancer, blood cancer, and others. Among these, the colon cancer segment accounted for the dominant market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. At home colon cancer tests, such as guaiac fecal occult blood test are used for screening for the signs of colorectal cancer. The increasing prevalence of colon cancer, with increasing technological advancements and early diagnostic initiatives, is promoting the market.
The genetic testing segment dominated the at-home cancer testing market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the test type, the at-home cancer testing market is divided into genetic testing, biomarker testing, immunological testing, and cell-free DNA testing. Among these, the genetic testing segment dominated the at-home cancer testing market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Genetic tests help in detecting hereditary genetic mutations, which may be responsible for causing cancer.
North America is expected to hold the majority share of the global At-Home Cancer Testing market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global At-Home Cancer Testing market during the forecast period. An increased awareness about cancer risk, along with advancements in diagnostic technologies, is propelling the at-home cancer testing market. Further, increased adoption of telehealth, remote patient monitoring, and technological advancements for more accurate and user-friendly at-home tests are propelling the market growth.
Asia Pacific is anticipated to grow at the fastest pace in the global at-home cancer testing market during the forecast period. The growing prevalence of cancer, along with an increasing adoption of international digital health approaches, is propelling the market. Implementation of strategic collaborations and partnerships for developing novel instruments is promoting the market of at-home cancer testing.
Major vendors in the global at-home cancer testing market are 23andMe, PathAI, Guardant Health, Egenomics, Quanterix, NantHealth, Oncocyte, Genomic Health, Exact Sciences, Myriad Genetics, Freenome, Invitae, CancerIQ, GRAIL, Thermo Fisher Scientific, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2025, Myriad Genetics, a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS, an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test.
- In September 2025, Healthmine, a leading member engagement and rewards platform for health plans, announced a partnership with Exact Sciences, a global leader in cancer diagnostics, to improve colorectal cancer screening completion rates.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the At-Home Cancer Testing market based on the below-mentioned segments:
Global At-Home Cancer Testing Market, By Sample Type
- Blood Sample
- Saliva Sample
- Urine Sample
- Tissue Sample
Global At-Home Cancer Testing Market, By Cancer Type
- Colon Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Others
Global At-Home Cancer Testing Market, By Test Type
- Genetic Testing
- Biomarker Testing
- Immunological Testing
- Cell-Free DNA Testing
Global At-Home Cancer Testing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?